American Airlines (AAL.US) are plunging around 15% today, with company's share price dropping to the lowest level since the beginning of November 2023. Company announced a cut to its profit outlook yesterday in the evening as well as departure of one of key executives, who helped reshape company's strategy.
American Airlines now expects lower adjusted EPS in Q2 2024. Forecast was lowered by around 17.3% based on forecast range midpoints. Meanwhile, total revenue per available seat mile is expected to see a deeper drop than previously assumed. While the company expects a slower cost growth, this is not enough revenue drop, leading to lower expectations for margins.
Company also said that Vasu Raja, Chief Commerical Officer, who helped refocus that company on leisure destinations will step down next month, in a sign that the latest strategy change of the airline may have been poorly received.
American Airlines Q2 outlook
- Adjusted EPS: $1.00-1.15, down from previous forecast of $1.15-1.45
- Total revenue per available seat mile: 5-6% decline, compared to previous forecast of 1-3% decline
- Cost per available seat mile, excluding fuel: 0-1% growth, compared to previous forecast of 1-3% growth
- Adjusted operating margin: 'about 8.5-10.5%', down from previous forecast of 'about 9.5-11.5%'
Source: XTB Research
American Airlines (AAL.US) slump 15% after lowering Q2 guidance and are trading at the lowest level since the beginning of November 2023. Source: xStation5
Nestlé: Steady Growth and Ambitious Restructuring Drive Share Price Surge
TSMC Earnings Preview: Will the Key Semiconductor Supplier Surprise the Market?
US Open: American Indices Rally on Anticipated End of Fed Balance Sheet Reduction
Bank of America, Wells Fargo, and Morgan Stanley: Q3 2025 Earnings Overview
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
